S Nagashima
- Co-authors
- Nikola L. VujanovićYoshinori SuminamiT L WhitesideTheresa L. WhitesideHiroshi KatoKazutaka HirabayashiRonald B. HerbermanKazuaki Chikamatsu
- Topics
- Immune Cell Function and Interaction (5 papers)RNA Interference and Gene Delivery (3 papers)Cell death mechanisms and regulation (2 papers)
- Partner nations
- United StatesJapanUnited Kingdom
In The Last Decade
S Nagashima
14 papers receiving 520 citations
Peers
Comparison fields: 5 of 68
- Immunology 255
- Molecular Biology 150
- Oncology 145
- Cancer Research 79
- Rheumatology 66
Countries citing papers authored by S Nagashima
This map shows the geographic impact of S Nagashima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Nagashima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Nagashima more than expected).
Fields of papers citing papers by S Nagashima
This network shows the impact of papers produced by S Nagashima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Nagashima. The network helps show where S Nagashima may publish in the future.
Co-authorship network of co-authors of S Nagashima
This figure shows the co-authorship network connecting the top 25 collaborators of S Nagashima. A scholar is included among the top collaborators of S Nagashima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Nagashima. S Nagashima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Anti-Inflammatory Profile of AS2444697, A Novel Interleukin-1 Receptor-Associated Kinase-4 Inhibitor | 2 |
| 2 | Suppression of a squamous cell carcinoma (SCC)-related serpin, SCC antigen, inhibits tumor growth with increased intratumor infiltration of natural killer cells. | 73 |
| 3 | 129 | |
| 4 | In vitro and in vivo characteristics of human squamous cell carcinoma of the head and neck cells engineered to secrete interleukin-2. | 21 |
| 5 | Human tumor antigen-specific T lymphocytes and interleukin-2-activated natural killer cells: comparisons of antitumor effects in vitro and in vivo. | 26 |
| 6 | 81 | |
| 7 | 3 | |
| 8 | Antitumor effects of cytolytic T lymphocytes (CTL) and natural killer (NK) cells in head and neck cancer. | 42 |
| 9 | 43 | |
| 10 | 11 | |
| 11 | Effects of recombinant human G-CSF, GM-CSF and IL-3 on phagocytosis, C3bi receptor expression and alkaline phosphatase activity of human neutrophils in peripheral blood and bone marrow | 1 |
| 12 | [CD8+ agranular lymphocyte proliferative disorder with T-cell receptor beta-chain gene rearrangement associated with thymoma and neutropenia]. | 4 |
| 13 | 90 | |
| 14 | 8 |
About S Nagashima
S Nagashima is a scholar working on Immunology, Immunology and Allergy and Emergency Medical Services, having authored 14 papers that have together received 534 indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (5 papers), RNA Interference and Gene Delivery (3 papers) and Cell death mechanisms and regulation (2 papers). The work is most often cited by research in Immunology (255 citations), Immunology and Allergy (34 citations) and Oncology (145 citations). S Nagashima has collaborated with scholars based in United States, Japan and United Kingdom. Frequent co-authors include Nikola L. Vujanović, Yoshinori Suminami, T L Whiteside, Theresa L. Whiteside, Hiroshi Kato, Kazutaka Hirabayashi, Ronald B. Herberman, Kazuaki Chikamatsu, Kazuhiko Okada and H Enokihara. Their work appears in journals such as Blood, The Journal of Immunology and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.